Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology

BACKGROUND: Genome-wide association studies have established clusterin (CLU) as a genetic modifier for late-onset Alzheimer’s disease (AD). Both protective and risk alleles have been identified which may be associated with its expression levels. However, the physiological function of clusterin in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fading, Swartzlander, Dan B., Ghosh, Anamitra, Fryer, John D., Wang, Baiping, Zheng, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849119/
https://www.ncbi.nlm.nih.gov/pubmed/33517893
http://dx.doi.org/10.1186/s13024-021-00426-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849119/
https://www.ncbi.nlm.nih.gov/pubmed/33517893
http://dx.doi.org/10.1186/s13024-021-00426-7

Ejemplares similares